Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   EBIT Growth(%) 29.026.6673.35-0.161.95

What is the latest EBIT Growth ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EBIT Growth ratio of SYNCOM FORMULATIONS (INDIA) is 29.02 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202429.02
Mar20236.66
Mar202273.35
Mar2017-0.16
Mar20161.95

How is EBIT Growth of SYNCOM FORMULATIONS (INDIA) Trending?

Years EBIT Growth % Change
Mar2024 29.02
335.74
Mar2023 6.66
-90.92
Mar2022 73.35
Positive
Mar2017 -0.16
Negative
Mar2016 1.95 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EBIT Growth ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,613.0 Cr 0.2% -6.2% -25.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,370.0 Cr 0.7% 0.4% -12.5% Stock Analytics
DIVIS LABORATORIES ₹160,087.0 Cr -1.7% 2% 16.7% Stock Analytics
CIPLA ₹126,308.0 Cr -0.9% 5.3% -3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,614.0 Cr -0.1% 0.6% 6.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,845.0 Cr 4.1% 7.6% -3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

0.2%

-6.2%

-25.6%

SENSEX

1.1%

1%

-0.9%


You may also like the below Video Courses